BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes.

During January, the number of shares and votes in BONESUPPORT HOLDING AB (PUBL) has increased with 22,000 due to the exercise of 110,000 warrants within the employee stock options program 2012/2022.

As per January 31, 2023, the total number of shares in BONESUPPORT HOLDING AB (publ) amounts to 66,196,635 shares, divided into 64,554,197 ordinary shares with one vote per share and 1,642,438 series C-shares with one-tenth of a vote per share, corresponding to a total of 64,718,440.8 votes.

For more information contact:

BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

This information is information that BONESUPPORT Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2023-01-31 09:00 CET.

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 213 million in 2021. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

© Modular Finance, source Nordic Press Releases